+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Rubella (German Measles) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768221
  • Report
  • April 2019
  • Region: Germany
  • 69 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • AstraZeneca Plc
  • Biological E Ltd
  • Cadila Healthcare Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Sanofi
  • MORE
The global clinical trial report- “2019 Rubella (German Measles) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rubella (German Measles). It presents in-depth analysis of Rubella (German Measles) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Rubella (German Measles).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Rubella (German Measles) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Rubella (German Measles)

The research work is prepared through extensive and continuous research on Rubella (German Measles) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Rubella (German Measles) patients are identified
  • The report includes panorama of Rubella (German Measles) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Rubella (German Measles) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AstraZeneca Plc
  • Biological E Ltd
  • Cadila Healthcare Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Sanofi
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Rubella (German Measles) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Rubella (German Measles) Clinical Trials by Region
2.2.2 Average Enrollment of Rubella (German Measles) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Rubella (German Measles) Treatment, 2019

3. Region wise Rubella (German Measles) Clinical Trials
3.1 Asia Pacific Rubella (German Measles) Clinical Trials by Country
3.2 Europe Rubella (German Measles) Clinical Trials by Country
3.3 North America Rubella (German Measles) Clinical Trials by Country
3.4 Middle East and Africa Rubella (German Measles) Clinical Trials by Country
3.5 South and Central America Rubella (German Measles) Clinical Trials by Country

4. Rubella (German Measles) Clinical Trial Trends
4.1 Start Year wise Rubella (German Measles) Clinical Trials
4.2 Phase wise Rubella (German Measles) Clinical Trials
4.3 Trial Status wise Rubella (German Measles) Clinical Trials
4.4 Trial Type wise Rubella (German Measles) Clinical Trials

5. Rubella (German Measles) Average Enrollment Trends
5.1 Average Enrollment in Rubella (German Measles) Trials by Year
5.2 Average Enrollment in Rubella (German Measles) Trials by Phase
5.3 Average Enrollment in Rubella (German Measles) Trials by Status
5.4 Average Enrollment in Rubella (German Measles) Trials by Type of Trial

6. Companies Participating in Rubella (German Measles) Clinical Trials
6.1 Rubella (German Measles) Trials by Sponsor Type
6.2 Rubella (German Measles) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Rubella (German Measles) Trials- Phase 1
7.2 Rubella (German Measles) Trials- Phase 2
7.3 Rubella (German Measles) Trials- Phase 3
7.4 Rubella (German Measles) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Rubella (German Measles) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Rubella (German Measles) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Rubella (German Measles) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Rubella (German Measles) Clinical Trials and Enrolment
Figure 7: North America - Country wise Rubella (German Measles) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Rubella (German Measles) Clinical Trials and Enrolment
Figure 9: Rubella (German Measles) Clinical Trials by Phase
Figure 10: Rubella (German Measles) Clinical Trials by Trial Status
Figure 11: Rubella (German Measles) Clinical Trials by Type
Figure 12: Rubella (German Measles) Clinical Trials by Sponsor Type
Figure 13: Rubella (German Measles) Clinical Trials by Leading Sponsors
Figure 14: Rubella (German Measles) Average Enrollment by Phase
Figure 15: Rubella (German Measles) Average Enrollment by Trial Status
Figure 16: Rubella (German Measles) Average Enrollment by Type
Figure 17: Rubella (German Measles)- Average Enrolment by Type of Sponsors
Figure 18: Rubella (German Measles)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Rubella (German Measles) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Rubella (German Measles) Clinical Trials and Enrolment
Table 5: Europe - Country wise Rubella (German Measles) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Rubella (German Measles) Clinical Trials and Enrolment
Table 7: North America - Country wise Rubella (German Measles) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Rubella (German Measles) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Rubella (German Measles) Average Enrollment by Phase
Table 15: Rubella (German Measles) Average Enrollment by Trial Status
Table 16: Rubella (German Measles) Average Enrollment by Type
Table 17: Rubella (German Measles)- Average Enrolment by Type of Sponsors
Table 18: Rubella (German Measles)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AstraZeneca Plc
  • Biological E Ltd
  • Cadila Healthcare Ltd
  • China National Pharmaceutical Group Corp
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Sanofi
  • Sanofi Pasteur MSD SNC
  • Serum Institute of India Ltd
  • Takeda Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll